|
|||||
|
|
Uterine cancer in Jewish Israeli BRCA1/2 mutation carriers |
|
| Authors: | Yael Laitman MSc Rachel Michaelson-Cohen MD Einat Levi Rakefet Chen-Shtoyerman PhD Orit Reish MD Sagi Josefsberg Ben-Yehoshua MD Rinat Bernstein-Molho MD Lital Keinan-Boker MD PhD Ora Rosengarten MD Barbara G. Silverman MD Tamar Perri MD Jacob Korach MD Pnina Mor MSc RN Noa Ephrat Ben-Baruch MD Ephrat Levy Lahad MD Eitan Friedman MD PhD the Israeli Consortium of Hereditary Breast Cancer |
| Affiliation: | 1. Oncogenetics Unit, Institute of Human Genetics, and Meirav High Risk Clinic, Chaim Sheba Medical Center, Tel-Hashomer, Israel;2. Genetics Institute and NOGA High Risk Clinic, Shaare Zedek Medical Center, Hebrew University School of Medicine, Jerusalem, Israel;3. Oncogenetics Clinic, Clinical Genetics Institute, Kaplan Medical Center, Rehovot, Hebrew University School of Medicine, Jerusalem, Israel;4. Genetics Institute, Assaf Harofe Medical Center, Zerifin, Israel;5. Breast Cancer Unit, Oncology Institute, Chaim Sheba Medical Center, Tel-Hashomer, Israel Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel;6. Israeli National Cancer Registry, Ministry of Health, Chaim Sheba Medical Center, Tel-Hashomer, Israel School of Public Health, University of Haifa, Haifa, Israel;7. Gyneco-Oncology Unit, Institute of Oncology, Shaare Zedek Medical Center, Hebrew University School of Medicine, Jerusalem, Israel;8. Israeli National Cancer Registry, Ministry of Health, Chaim Sheba Medical Center, Tel-Hashomer, Israel;9. Department of Gyneco-Oncology, Sheba Medical Center, Tel-Hashomer, Israel Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel;10. Oncology Department, Kaplan Medical Center, Rehovot, Hebrew University School of Medicine, Jerusalem, Israel |
| Abstract: | |
| Keywords: | BRCA1/2 germline mutations uterine cancer uterine sarcoma risk reducing surgery Jewish women |